ADC Therapeutics (ADCT) executive compensation, 2026 proxy

Ameet Mallik, Chief Executive Officer, was paid $2.5M in 2025, up 33% from $1.8M the year before.

Filed
April 20, 2026
Annual meeting
June 1, 2026
Pay year
2025
Named executives
3
CEO total pay
$2.5M+33% vs prior year
CEO pay in equity
43%$1M in awards
Prior say-on-pay support
88%of votes cast
CEO Salary
$776,084For fiscal year 2025
CEO Stock Awards
$1,046,500Grant date fair value
2025 Net Loss
$142.6MNet loss for the fiscal year

How Mallik was paid

$2.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary32%Stock awards43%Non-equity incentive24%All other compensation2%

Named executive officers

ExecutiveTotal
Ameet MallikChief Executive Officer$2,453,150
Jose “Pepe” CarmonaChief Financial Officer$1,247,003
Mohamed ZakiChief Medical Officer$1,515,566

What changed and why

  • $2.5MChief executive officer total compensation increased to $2,453,150 in 2025 from $1,837,628 in 2024.
  • $1MStock awards granted to the chief executive officer totaled $1,046,500 in 2025.
  • $582KNon-equity incentive plan compensation for the chief executive officer was $582,063 in 2025.
  • 87.9%Shareholders approved the prior executive compensation program with 87.9% support at the 2025 annual meeting.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.